Synergism of prenylflavonoids from Morus alba root bark against clinical MRSA isolates.
Journal:
Phytomedicine : international journal of phytotherapy and phytopharmacology
PMID:
29433688
Abstract
BACKGROUND: Clinical methicillin-resistant Staphylococcus aureus (MRSA) is a thorny problem in current anti-infective therapeutics and a challenge of new drug development. Plant prenylflavonoids possess anti-MRSA activity, but few of the prenylflavonoids have been reported the synergistic anti-MRSA effect when they are used in combination with conventional antibacterial agents.